2Temple R. Are surrogate markees adequate to assess cardiovascular drugs? JAMA1999;282:790-795.
3Drugs for hypertension. Med Left. 1999;41:23-28.
4The sixth report of the Joint National Committee on Prevention. Deteciton, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446
5Lasagna L. A plea for the "nat uralistic" study Of medicines. Eur J Clin Pharmacol 1974.7:153-154.
6The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascutar events In hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2000;283:1967-1975.
7Armitage P. Sequential Medical Trials. 2nd ed. New York. NY: John Wiley &Sons Inc; 1975.
8Drug Evaluations. 6th ed. Chicago, Ⅲ: American Medical Association; 1986.
